Literature DB >> 18230871

Complications associated with the arterial puncture closure device--Angio-Seal.

Alexander Kadner1, Jürg Schmidli, Igor Schwegler, Florian Dick, Florian Schönhoff, Thierry Carrel, Hannu Savolainen.   

Abstract

BACKGROUND: Arterial puncture closure devices (APCD) are frequently used after cardiac catheterization. Here, the diagnosis and therapy of femoral artery complications after the use of the Angio-Seal APCD is reported. PATIENTS AND METHODS: The Angio-Seal APCD was deployed in 1600 patients undergoing transfemoral catheterization.
RESULTS: In 7 of 1600 cases (0.4%) vascular complications occurred following Angio-Seal deployment. Diagnosis was made by duplex sonography. Intraoperative findings consisted of a complete occlusion with dissection of the femoral artery in all patients. In 6 cases, the femoral bifurcation had to be reconstructed after endarterectomy. Follow-up is complete with a mean of 6 months.
CONCLUSION: The Angio-Seal device should not be used for closure of the superficial femoral artery and in patients with severe arteriosclerosis. The application of arteriography as well as the use of ultrasound-guided puncture is advisable. In all cases, surgical intervention was successful and an adequate therapy for management of complications.

Entities:  

Mesh:

Year:  2008        PMID: 18230871     DOI: 10.1177/1538574407312657

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  9 in total

1.  Radioembolization complicated by dissection of the common femoral artery.

Authors:  Sarah G Deitch; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  Initial experience with the AXERA 2 Femoral Access System in neurovascular procedures.

Authors:  Ramesh Grandhi; Nathan T Zwagerman; Xiaoran Zhang; Stephanie H Chen; Ashutosh P Jadhav; Tudor Jovin; Brian T Jankowitz
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

3.  Incidence of delayed angiographic femoral artery complications using the EXOSEAL vascular closure device.

Authors:  Ramesh Grandhi; Xiaoran Zhang; David Panczykowski; Phillip Choi; Christopher T Hunnicutt; Ashutosh P Jadhav; Andrew F Ducruet; Tudor Jovin; Brian Jankowitz
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

4.  Late onset iatrogenic limb ischaemia after deployment of an Angio-Seal vascular closure device.

Authors:  Rama K Krishna; Nisharahmed Kherada; Nirat Beohar
Journal:  BMJ Case Rep       Date:  2015-04-26

5.  Fluoroscopic guided fogarty embolectomy for an angio-seal embolism in the popliteal artery.

Authors:  Doran Hong; Seung Hwa Lee; Hwan Hoon Chung; Bo Kyoung Seo; Sang Hoon Cha; Kee Yeol Lee; Jeong Cheon Ahn
Journal:  Korean J Radiol       Date:  2013-07-17       Impact factor: 3.500

6.  Usefulness of duplex ultrasonography to detect collagen sponge misplacement into the arterial lumen during the use of Angio-Seal: A case report.

Authors:  Masayo Sugawara; Katsuyuki Hoshina; Mayumi Chigira; Hirohide Suzuki; Masao Daimon; Toshio Takayama; Yoshikazu Ono; Yutaka Yatomi
Journal:  SAGE Open Med Case Rep       Date:  2021-03-30

7.  Ease of using a dedicated percutaneous closure device after inadvertent cannulation of the subclavian artery: case report.

Authors:  Arnaud Devriendt; Emmanuel Tran-Ngoc; Philippe Gottignies; José Castro-Rodriguez; Oliver Lomas; Sophie Jamart; Sébastien Knecht
Journal:  Case Rep Med       Date:  2009-06-17

8.  Femoral pseudoaneurysms requiring surgical treatment.

Authors:  Hannu Savolainen; Iris Baumgartner; Juerg Schmidli; George Heller; Do-Dai Do; Torsten Willenberg
Journal:  Trauma Mon       Date:  2012-01-15

9.  Safety and efficacy of the StarClose vascular closure system following 8-Fr sheath placement for intra-aortic balloon pump: a single-center analysis of 42 consecutive patients.

Authors:  Guang Chu; Wenyi Yang; Guobing Zhang; Zhi Zhang; Shaowen Liu; Baogui Sun; Fang Wang
Journal:  Med Princ Pract       Date:  2014-04-23       Impact factor: 1.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.